Market Cap

Avricore Health, Inc. Market Capitalization:

C$17.4 Million

CAD as of Jan. 1, 2024

US$13.2 Million

business Avricore Health, Inc. Company Profile

Avricore Health, Inc. Main Stock Listing

TSXV: AVCR

Market Capitalization History of Avricore Health, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Avricore Health, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 C$17.4 M -41.06%
Jan. 1, 2023 C$29.6 M 100.00%
Jan. 1, 2022 C$14.8 M -38.78%
Jan. 1, 2021 C$24.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Avricore Health, Inc. Categories

Canada languages Healthcare languages Diagnostics & Research
Canada Healthcare Canada Diagnostics & Research

Stocks & Indices

Avricore Health, Inc. has the following listings and related stock indices.


Stock: TSXV: AVCR

Stock: OTC: AVCRF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.